DOXEPIN HYDROCHLORIDE (doxepin) by Teva is unclear; however, doxepin's effect could be mediated through antagonism of the h1 receptor . Approved for insomnia characterized by difficulties with sleep maintenance, insomnia. First approved in 2013.
Drug data last refreshed 18h ago
unclear; however, doxepin's effect could be mediated through antagonism of the H1 receptor .
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia
Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome
Worked on DOXEPIN HYDROCHLORIDE at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.